Shares of Oxford BioDynamics Plc (LON:OBD – Get Free Report) reached a new 52-week low during trading on Tuesday . The stock traded as low as GBX 0.90 ($0.01) and last traded at GBX 0.98 ($0.01), with a volume of 2947997 shares changing hands. The stock had previously closed at GBX 1.06 ($0.01).
Oxford BioDynamics Stock Performance
The firm’s 50 day moving average is GBX 1.36 and its 200 day moving average is GBX 4.62. The company has a debt-to-equity ratio of 370.22, a quick ratio of 2.80 and a current ratio of 0.68. The stock has a market cap of £4.25 million, a P/E ratio of -22.70 and a beta of 0.42.
Insider Activity
In related news, insider David Holbrook bought 49,653 shares of the company’s stock in a transaction on Monday, October 28th. The shares were bought at an average price of GBX 1 ($0.01) per share, with a total value of £496.53 ($620.58). Company insiders own 16.78% of the company’s stock.
About Oxford BioDynamics
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Featured Articles
- Five stocks we like better than Oxford BioDynamics
- How to Capture the Benefits of Dividend Increases
- Micron Stock Under $100: Seize the AI-Driven Upside
- Canadian Penny Stocks: Can They Make You Rich?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What Investors Need to Know About Upcoming IPOs
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
